Search

everythinglearnresearchcommunity

for

Search:↓

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

COVID-19 may cause hair loss due to infection stress or treatments.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Infants with scalp injuries developed a skin condition that improved with steroid creams.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

The combination of calcipotriene and betamethasone is more effective and has fewer side effects for treating psoriasis.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.